Loading data for FBRX — first visit, this takes a few seconds.
Forte Biosciences Inc. (FBRX)
: FBRX
· Real-Time Price · USD
n/a
n/a (n/a)
At close: Invalid Date
76.92
+0.00%
After-hours: 7:49 PM
The price, the headline numbers and the latest news, in one place.
Forte Biosciences Inc. (FBRX) Stock Price, Analysis & Data
No data available
| Bid | n/a |
| Market Cap | n/a |
| Revenue (ttm) | n/a |
| Net Income (ttm) | -87.94M |
| 2.65 | |
| n/a | |
| n/a | |
| -19.5 | |
| P/B (ttm) | 32.65 |
| P/S (ttm) | n/a |
| Earnings Date | n/a |
| Ask | n/a |
| Volume | NaN |
| Avg. Volume (20D) | n/a |
| Open | n/a |
| Previous Close | n/a |
| Day's Range | n/a - n/a |
| 52-Week Range | n/a - n/a |
| Analyst | n/a |
| Price Target | n/a |
| Dividends | n/a |
| Ex-Dividend Date | n/a |
About FBRX
Forte Biosciences, Inc. operates as a clinical-stage biopharmaceutical company in the United States. The company's lead product candidate is the FB-102, a proprietary anti-CD122 monoclonal antibody therapeutic candidate for various autoimmune and autoimmune-related indications, such as celiac disease, vitiligo, alopecia areata, and type 1 diabetes. Forte Biosciences, Inc. is headquartered in Dallas, Texas....
Industry Biotechnology
Sector Healthcare
IPO Date Apr 13, 2017
Employees 23
Stock Exchange NasdaqCM
Ticker Symbol FBRX
Website https://www.fortebiorx.com
Financial Performance
In 2025, Forte Biosciences's revenue was 0, an increase of undefined% compared to the previous year's 0. Earnings were -69.38M, an increase of 95.54%.
Financial Statements